Literature and original data on patients with chronic megakaryocytic leukem
ia (CML) for the last 27 years are reviewed. Different chemotherapy program
s in CML including intron A are compared. Remission was more frequently ach
ieved by myelosan treatment, but intron A was also effective in CML (respon
se > 50%) and is indicated in fertile women.